about
Association between serum interleukin-35 levels and severity of acute pancreatitis.sPD-L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis.Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model.Adaptive Immune Cell Dysregulation and Role in Acute Pancreatitis Disease Progression and Treatment.Decreased MIZ1 Expression in Severe Experimental Acute Pancreatitis: A Rat Study.Early enteral nutrition improves intestinal immune barrier in a rat model of severe acute pancreatitis.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunomodulatory therapies for acute pancreatitis.
@ast
Immunomodulatory therapies for acute pancreatitis.
@en
Immunomodulatory therapies for acute pancreatitis.
@nl
type
label
Immunomodulatory therapies for acute pancreatitis.
@ast
Immunomodulatory therapies for acute pancreatitis.
@en
Immunomodulatory therapies for acute pancreatitis.
@nl
prefLabel
Immunomodulatory therapies for acute pancreatitis.
@ast
Immunomodulatory therapies for acute pancreatitis.
@en
Immunomodulatory therapies for acute pancreatitis.
@nl
P2093
P2860
P1476
Immunomodulatory therapies for acute pancreatitis.
@en
P2093
P2860
P304
P356
10.3748/WJG.V20.I45.16935
P407
P577
2014-12-07T00:00:00Z